[1]
|
New arylidene-linked chromane-2,4-dione analogs as potential leads for diabetic management; syntheses, α-amylase inhibitory, and radical scavenging activities
Chemical Papers,
2023
DOI:10.1007/s11696-022-02648-5
|
|
|
[2]
|
New arylidene-linked chromane-2,4-dione analogs as potential leads for diabetic management; syntheses, α-amylase inhibitory, and radical scavenging activities
Chemical Papers,
2023
DOI:10.1007/s11696-022-02648-5
|
|
|
[3]
|
Designing Potent α-Glucosidase Inhibitors: A Synthesis and QSAR Modeling Approach for Biscoumarin Derivatives
ACS Omega,
2023
DOI:10.1021/acsomega.3c02868
|
|
|
[4]
|
In silico and in vitro analysis of PPAR – α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat
Computers in Biology and Medicine,
2022
DOI:10.1016/j.compbiomed.2022.105796
|
|
|
[5]
|
Cichoriin, a Biocoumarin, Mitigates Oxidative Stress and Associated Adverse Dysfunctions on High-Fat Diet-Induced Obesity in Rats
Life,
2022
DOI:10.3390/life12111731
|
|
|
[6]
|
In silico and in vitro analysis of PPAR – α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat
Computers in Biology and Medicine,
2022
DOI:10.1016/j.compbiomed.2022.105796
|
|
|
[7]
|
Hetarylcoumarins: Synthesis and biological evaluation as potent α -glucosidase inhibitors
Bioorganic Chemistry,
2017
DOI:10.1016/j.bioorg.2017.05.009
|
|
|
[8]
|
Antiproliferative and cytotoxic secondary metabolites from fruits of Leplaea mayombensis
Natural Product Research,
2017
DOI:10.1080/14786419.2017.1402321
|
|
|